Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 67 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 8609716

    Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  2. US 8609607

    Modified defensins and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  3. US 8603468

    Neutralization of HCV

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  4. US 8603978

    Use of muramyl dipeptide (MDP) for treating inflammation

    The United States of America, as represented by the Secretary, Department of Health and Humand Services · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  5. US 8603808

    Leishmania vaccine using sand fly salivary immunogen

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  6. US 8603462

    Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction

    The United States of America—Department of Veterans Affairs · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  7. US 8597876

    Method of treating HIV infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  8. US 8597660

    Therapeutic approach to neurodegenerative disorders using a TFP5-peptide

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  9. US 8597883

    Biomarkers for cancer-related fatigue and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  10. US 8591889

    Human monoclonal antibodies specific for CD22

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

  11. US 8586055

    DNA immunization protocols

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted

  12. US 8580944

    Suppressors of CpG oligonucleotides and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted

  13. US 8580927

    Engineered antibody constant domain molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted

  14. US 8575375

    Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  15. US 8574853

    Monoclonal antibodies that neutralize anthrax toxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  16. US 8575121

    Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  17. US 8568977

    Compositions and methods for diagnosis and treatment of tumors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  18. US 8569028

    Method for encapsulation of microparticles

    The United States of America, as represented by the Secretary of the Agriculture · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  19. US 8568714

    Lys K endolysin is synergistic with lysostaphin against MRSA

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  20. US 8568739

    Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  21. US 8569377

    Methods for treating spinal cord injury with a compound that inhibits a NCCA-ATP channel

    The United States of America as represented by the Department of Veteran Affairs · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  22. US 8563599

    Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof

    THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF AGRICULTURE · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  23. US 8557789

    Method of treating inflammatory arthropathies with supressors of CPG oligonucleotides

    The United States of America as represented by the Secretary of the Development of Health and Human Services · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  24. US 8557844

    Substrate reduction therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.